dc.source | Bibliografía 1. National Hospital Discharge Survey. Survey results and products. Available at Center for Disease Control and Prevention, Atlanta (2009) 2. UK National Joint Registry 3. Kurtz, K. Ong, E. Lau, F. Mowat, M. Halpern. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am, 89 (4) (2007), pp. 780–785 4. Clohisy JC, Calvert G, Tull F, McDonald D, Maloney WJ. Reasons for revision hip surgery: a retrospective review. Clin Orthop Relat Res. 2004 Dec;(429):188-92. 5. Kurtz SM, Lau E, Schmier J, Ong KL, Zhao K, Parvizi J. Infection burden for hip and knee arthroplasty in the United States. J Arthroplasty. 2008 Oct;23(7):984-91. 6. T.P. Sculco. The economic impact of infected joint arthroplasty. Orthopedics, 18 (9) (1995), pp. 871–873 7. Workgroup Convened by Musculoskeletal Infection Society. New definition for periprosthetic joint infection. J Arthroplasty, 26 (8) (Dec 2011), p. 1136 8. Parvizi J1, Gehrke T; International Consensus Group on Periprosthetic Joint Infection Definition of periprosthetic joint infection. J Arthroplasty. 2014 Jul;29(7):1331. doi: 9. Kanellakopoulou K, Panagopoulos P, Giannitsioti E, Tsaganos T, Carrer DP, Efstathopoulos N, Giamarellos-Bourboulis EJ. In vitro elution of daptomycin by a synthetic crystallic semihydrate form of calcium sulfate, stimulant. Antimicrob Agents Chemother. 2009 Jul;53(7):3106-7 10. Howlin RP, Brayford MJ, Webb JS, Cooper JJ, Aiken SS, Stoodley P. Antibiotic-loaded synthetic calcium sulfate beads for prevention of bacterial colonization and biofilm formation in periprosthetic infections. Antimicrob Agents Chemother. 2015 Jan;59(1):111-20. doi: 10.1128/AAC.03676-14. Epub 2014 Oct 13. 11. Shehab D, Elgazzar A, Collier D. Heterotopic ossification. J Nucl Med 2002; 43:346-353. 12. Iorio R, Healy WL. Heterotopic ossification after hip and knee arthroplasty: risk factors, prevention, and treatment. J Am Acad Orthop Surg. 2002;10(6):409-416 13. Liu K, Tripp S, Layfield LJ. Heterotopic ossification: review of histologic findings and tissue distribution in a 10-year experience. Pathol Res Pract. 2007;203(9):633-640. 14. Baird EO, Kang QK. Prophylaxis of heterotopic ossification—an updated review. J Orthop Surg Res. 2009;4:12 15. Suda RK, Billings PC, Egan KP, et al. Circulating osteogenic precursor cells in heterotopic bone formation. Stem Cells. 2009;27(9):2209-2219. 16. Brooker AF, Bowerman JW, Robinson RA, Riley LH Jr. Ectopic ossification following total hip replacement. Incidence and a method of classification. J Bone Joint Surg Am. 1973;55(8):1629-1632 17. Della Valle AG, Ruzo PS, Pavone V, Tolo E, Mintz DN, Salvati EA. Heterotopic ossification after total hip arthroplasty: a critical analysis of the Brooker classification and proposal of a simplified rating system. J Arthroplasty. 2002;17(7):870-875 18. Arcq M. Ectopic ossification: a complication after total hip replacement (author’s transl) [in German]. Arch Orthop Unfallchir. 1973;77(2):108-131 19. H.W. Buchholz, H. Engelbrecht. Über die Depotwirkung einiger Antibiotika bei Vermischung mit dem Kunstharz Palacos. Chirurg, 41 (1970), pp. 511–515 20. L.F. Peltier. The use of Plaster of Paris to fill defects in bone. Clin Orthop, 21 (1961), pp. 1–29 21. A.S. Coetzee, Regeneration of bone in the presence of calcium sulfate, Arch Otolaryngo, 106 (1980), pp. 405–409 22. Strauss A. Lokaler Antibiotikumträger aus Kalziumsulfat: Verträglichkeit im Gewebe und Pharmakokinetik der angewendeten Antibiotika nach Implantation in Kaninchen. Biomaterialien in der Medizin. Giessen: Köhler; 1999. p. 105–8. 23. G.H. Lee, J.G. Khoury, J.E. Bell, J.A. Buckwalter. adverse reactions to OsteoSet bone graft substitute, the incidence in a consecutive series. Iowa Orthop J, 22 (2002), pp. 35–38 24. D. Robinson, D. Alk, J. Sandbank, R. Farber, N. Halperin. Inflammatory reactions associated with a calcium sulfate bone substitute. Ann Transpl, 4 (1999), pp. 91–97 25. Petrova. Gipsfüllung von Knochenhöhlen bei Osteomyelitis. Zentralorg Ges Chir, 43 (1928), p. 485 26. V. Dacquet, A. Varlet, R.N. Tandogan, M.M. Tahon, L. Fournier, F. Jehl, H. Monteil, G. Bascoulergue. Antibiotic-impregnated Plaster of Paris beads—trials with teicoplanin. Clin Orthop, 282 (1992), pp. 241–249 27. Turner TM, Urban RM, Gitelis S, Sumner DR, Haggard WO, Parr JE. Antibiotic delivery from calcium sulfate as a synthetic bone graft. Fourth Combined Meeting of the American and European Musculoskeletal Tumor Societies, 1998. Washington, DC. 28. M. McKee, L. Wild, E. Schemitsch, J. Waddell. The use of an antibiotic-impregnated, osteoconductive, bioabsorbable bone substitute in the treatment of infected long bone defects: early results of a prospective trial. J Orthop Trauma, 16 (2002), pp. 622–627 29. Arbeláez W, Farias P, Suescun J. Osificaciones heterotopicas, en pacientes sometidos a reemplazo total de cadera primario mediante abordaje lateral indirecto modificado, en el hospital militar central de Bogotá en los años 2005-2008. http://repository.unimilitar.edu.co/bitstream/10654/10323/2/ArbelaezWilliam2011.pdf | |